[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.184.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 10, 1975

Ascorbic Acid and the Common ColdEvaluation of Its Efficacy and Toxicity

Author Affiliations

Dr. Dykes is Senior Scientist, AMA Department of Drugs. Dr. Meier is Professor, departments of statistics and pharmacological and physiological sciences, University of Chicago.

JAMA. 1975;231(10):1073-1079. doi:10.1001/jama.1975.03240220051025
Abstract

We reviewed the clinical data relating to the efficacy and safety of pharmacologic doses of ascorbic acid in the prevention and treatment of the common cold. Although one study tentatively supports the hypothesis that such doses of ascorbic acid may be efficacious, a second study by the same group did not confirm the significant findings, and no clear, reproducible pattern of efficacy has emerged from the review of all the evidence. Similarly, there is currently little adequate evidence on either the presence or the absence of serious adverse reactions to such doses of ascorbic acid, although many such reactions have been hypothesized. The unrestricted use of ascorbic acid for these purposes cannot be advocated on the basis of the evidence currently available.

(JAMA 231:1073-1079, 1975)

×